fda announcement semaglutide approves Wegovy pill The FDA's Decision to Ban

The entire process helps reduce your food cravings and controls your blood sugar levels which helps you to lose weight

These higher doses are not yet approved for clinical use

Unlike earlier-generation weight-management agents, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormonal receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may improve fat metabolism [12] [13] Glucagon receptor increases energy expenditure and may reduce hepatic steatosis, as suggested by imaging data (MRI-PDFF) from Phase 2 trials, though this effect requires confirmation in larger studies [2] [5] This triple-agonist mechanism distinguishes retatrutide from agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist), and is thought to produce more pronounced reductions in body weight and improvements in metabolic parameters

Our specialists carefully evaluate each patient to ensure that Ozempic is a safe and effective option for their weight management goals

Follow the plan, track progress, and message your care team anytime